Anúncio
Anúncio
MGNX
MacroGenics, Inc.
1.81
USDPatrocinado
+0.11
+6.76%
07 de jan., 15:59 UTC -5
Encerrado
Pós-Mercado
1.78
-0.04
-2.15%
Relatórios de Lucros MGNX
Rácio de surpresa positiva
MGNX separação 17 de 40 últimas estimativas.
43%
Próximo Relatório
Data do Próximo Relatório
18 de mar. de 2026
Estimate for Q4 25 (Revenue/ EPS)
$23.10M
/-$0.29
Mudanças implicadas de Q3 25 (Revenue/ EPS)
-68.29%
/-207.41%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
+19.34%
/+16.00%
MacroGenics, Inc. earnings per share and revenue
On 12 de nov. de 2025, MGNX reported earnings of 0.27 USD per share (EPS) for Q3 25, beating the estimate of -0.50 USD, resulting in a 153.84% surprise. Revenue reached 72.84 milhão, compared to an expected 14.99 milhão, with a 385.79% difference. The market reacted with a +8.84% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 9 analistas forecast an EPS of -0.29 USD, with revenue projected to reach 23.10 milhão USD, implying an diminuir of -207.41% EPS, and diminuir of -68.29% in Revenue from the last quarter.
FAQ
What were MacroGenics, Inc.'s earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, MacroGenics, Inc. reported EPS of $0.27, beating estimates by 153.84%, and revenue of $72.84M, 385.79% above expectations.
How did the market react to MacroGenics, Inc.'s Q3 2025 earnings?
The stock price moved up 8.84%, changed from $1.47 before the earnings release to $1.60 the day after.
When is MacroGenics, Inc. expected to report next?
The next earning report is scheduled for 18 de mar. de 2026.
What are the forecasts for MacroGenics, Inc.'s next earnings report?
Based on 9
analistas, MacroGenics, Inc. is expected to report EPS of -$0.29 and revenue of $23.10M for Q4 2025.
Which companies are reporting earnings today?
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio